Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals

FEMS Microbiology Reviews

Volumn 26, Issue 1, 2002, Pages 3-16

  Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Fluoroquinolone resistance; Salmonella enterica

Indexed keywords

ALANINE; ASPARTIC ACID; CHLORAMPHENICOL; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GLUTAMIC ACID; GLYCINE; PHENYLALANINE; PROTEIN SUBUNIT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TETRACYCLINE; TYROSINE; VALINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; DRUG SENSITIVITY; ESCHERICHIA COLI; FOOD; GENE MUTATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SALMONELLA ENTERICA; SALMONELLA TYPHI; SALMONELLOSIS; SEROTYPE;

ANIMALS; ANTI-INFECTIVE AGENTS; CHICKENS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MEAT; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; SWINE;

ANIMALIA; ESCHERICHIA COLI; SALMONELLA; SALMONELLA ENTERICA;

EID: 0036241788     PISSN: 01686445     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6445(01)00076-6     Document Type: Review

References (91)

1. The chicken, the egg and Salmonella enteritidis
2. Antimicrobial agents, general considerations, Section IX, Chemotherapy of microbial diseases
3. The successful treatment of multiresistant non-enteric salmonellosis with seven day oral ciprofloxacin
4. The interaction of drugs with DNA gyrase: A model for the molecular basis of quinolone action
5. Crystal structure of the breakage-reunion domain of DNA gyrase
6. Mechanisms of fluoroquinolone resistance: An update 1994-1998
7. The high-resolution crystal structure of 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors
8. A cluster of genes that affects nucleoid segregation in Salmonella typhimurium
9. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
10. Broad-host-range gyrase A gene probe
11. Quinolone resistance in Salmonella: Clinical experience
12. Mutations in the gyrA gene of quinolone-resistant Salmonella serotypes isolated from man and animals
13. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
14. Ciprofloxacin-resistance in clinical isolates Salmonella typhimurium obtained from two patients
15. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones
16. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction
17. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex
18. Mechanism of action of quinolones against Escherichia coli DNA gyrase
19. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance
20. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104
21. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing
22. Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs
23. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium
24. Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella
25. Epidemic Salmonella typhimurium DT104-a truly international epidemic clone
26. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype typhimurium DT104 isolates
27. A novel gyrB mutation in a fluoroquinolone-resistance clinical isolate of Salmonella typhimurium
28. Quinolone resistance in Salmonella spp.: Veterinary pointers
29. High-level fluoroquinolone resistance in Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes
30. Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany
31. Ciprofloxacin and the fluoroquinolones - New concepts on the mechanism of action and resistance
32. Quinolone-resistant Salmonella typhi in Viet Nam: Basis of resistance and clinical response to treatment
33. Ciprofloxacin resistance in Campylobacter jejuni isolates: Detection of gyrA resistance mutations by mismatch amplifimutation assay PCR and DNA sequence analysis
34. Role of mutations in the gyrA and parC genes of 196 nalidixic acid-resistant Salmonella serotypes isolated from animals
35. Genetic methods for assessing antimicrobial resistance
36. Molecular detection of antimicrobial resistance
37. Antimicrobial drug resistance in non-typhoidal salmonellas from humans in England and Wales in 1999: Decrease in multiple resistance in Salmonella enterica serotypes Typhimurium, Virchow, and Hadar
38. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. Enterica serotype typhimurium isolates from humans and animals
39. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field
40. Quinolone resistance among Salmonella enterica from cattle broilers, and swine in Denmark
41. Decreased susceptibility to ciprofloxacin in outbreak associated multiresistant Salmonella typhimurium DT104
42. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli isolated from humans and animals
43. Genetic evidence for a role of parC mutations in development of high level fluoroquinolone resistance in Escherichia coli
44. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli
45. Mechanism of quinolone uptake into bacterial cells
46. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli
47. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants
48. Absence of mutations in marRAB or soxRS in acrB over-expressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli
49. Salicylate induction of antibiotic resistance in Escherichia coli: Activation of the mar operon and a mar-independent pathway
50. Non-inheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12
51. Characterisation of marR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli
52. Organic solvent tolerance and antibiotic resistance increased by overexertion of marA in Escherichia coli
53. Role of the acrB locus in organic solvent tolerance mediated by expression of marA, soxS, or robber in Escherichia coli
54. Selection of multiply-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: Roles of the mar and acrAB loci
55. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli
56. Mechanisms of fluoroquinolone resistance: State of the art 1992
57. The emergence of ciprofloxacin resistance in Salmonella typhimurium
58. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium
59. Multiresistant Salmonella and fluoroquinolones
60. Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess
61. The Salmonella typhimurium mar locus: Molecular and genetic analysis and assessment of its role in virulence
62. Identification of SoxS-regulated genes in Salmonella enterica serovar Typhimurium
63. Salmonella typhimurium TnphoA mutants with increased sensitivity to biological and chemical detergents
64. Salmonella typhimurium acrB-like gene: Identification and role in resistance to biliary salts and detergents and in murine infection
65. Multiple efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains
66. Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB/c mice
67. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium
68. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12
69. RobA-induced multiple antibiotic resistance largely depends on activation of the AcrAB efflux
70. Active efflux of bile salts by Escherichia coli
71. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar typhimurium)
72. Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar typhimurium DT104
73. An outbreak of multidrug-resistant, quinolone-resistant, Salmonella enterica serotype typhimurium DT104
74. Fluoroquinolone resistance in Salmonella: A web discussion
75. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996
76. Increase in multiple antibiotic resistance in non-typhoidal salmonellas from humans in England and Wales: A comparison of data 1994 and 1996
77. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: Implications for the use of fluoroquinolones in food animals
78. A study of culture positive multidrug resistant enteric fever-changing pattern and emerging resistance to ciprofloxacin
79. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom
80. Short course of ofloxacin for treatment for multidrug-resistant typhoid
81. Two or three days of ofloxacin in the treatment for uncomplicated multi-drug resistant typhoid fever in children
82. Effects on growth of single short courses of fluoroquinolones
83. Summary of an international workshop on typhoid fever
84. Multiresistant Salmonella organisms in India
85. Quinolone resistance from a transferable plasmid
86. Evolution of resistance to quinolones in Salmonella enterica in our setting
87. Harmonization of antibiotic susceptibility testing for Salmonella: Results of a study by 18 national reference laboratories within the European Union-funded Enter-net group